GKB Ophthalmics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Krishna Gupta

Chief executive officer

₹4.7m

Total compensation

CEO salary percentage	76.0%
CEO tenure	42.9yrs
CEO ownership	29.6%
Management average tenure	no data
Board average tenure	1.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Krishna Gupta's remuneration changed compared to GKB Ophthalmics's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2024	n/a	n/a	-₹36m
Jun 30 2024	n/a	n/a	-₹36m
Mar 31 2024	₹5m	₹4m	-₹28m
Dec 31 2023	n/a	n/a	-₹38m
Sep 30 2023	n/a	n/a	-₹36m
Jun 30 2023	n/a	n/a	-₹16m
Mar 31 2023	₹5m	₹4m	-₹2m
Dec 31 2022	n/a	n/a	₹24m
Sep 30 2022	n/a	n/a	₹43m
Jun 30 2022	n/a	n/a	₹31m
Mar 31 2022	₹5m	₹4m	₹13m
Dec 31 2021	n/a	n/a	₹17m
Sep 30 2021	n/a	n/a	₹10m
Jun 30 2021	n/a	n/a	₹11m
Mar 31 2021	₹4m	₹3m	-₹9m
Dec 31 2020	n/a	n/a	-₹21m
Sep 30 2020	n/a	n/a	-₹22m
Jun 30 2020	n/a	n/a	-₹32m
Mar 31 2020	₹4m	₹3m	-₹18m
Dec 31 2019	n/a	n/a	-₹3m
Sep 30 2019	n/a	n/a	-₹23m
Jun 30 2019	n/a	n/a	-₹14m
Mar 31 2019	₹4m	₹3m	-₹11m
Mar 31 2018	₹4m	₹3m	-₹10m

Compensation vs Market: Krishna's total compensation ($USD56.06K) is above average for companies of similar size in the Indian market ($USD42.61K).

Compensation vs Earnings: Krishna's compensation has increased whilst the company is unprofitable.

CEO

Krishna Gupta (84 yo)

42.9yrs

Tenure

₹4,737,029

Compensation

Mr. Krishna Gopal Gupta serves as the Chairman and Managing Director at GKB Ophthalmic Limited serves as its Director since December 10, 1981. Mr. Gupta serves as Chairman of Prime Lenses Pvt. Ltd.He has...

Board Members

Name	Position	Tenure	Compensation	Ownership
Krishna Gupta	Chairman & MD	42.9yrs	₹4.74m	29.65% ₹ 144.4m
Cedric Lobo	Senior Manager of HR & Administration and Non Independent	less than a year	no data	no data
Vikram Gupta	Non-Executive Director	28.3yrs	₹30.00k	8.39% ₹ 40.9m
Shashi Katreddi	Independent Non-Executive Director	9.7yrs	₹110.00k	no data
Ninad Kamat	Independent & Non Executive Director	less than a year	no data	no data
Purushottam Mantri	Independent & Non-Executive Director	1.4yrs	₹120.00k	no data
Sandhya Kamat	Additional Independent & Non-Executive Director	less than a year	no data	no data

1.4yrs

Average Tenure

63yo

Average Age

Experienced Board: 533212's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.

GKB Ophthalmics Management

Management criteria checks 0/4

Key information

Recent management updates

GKB Ophthalmics Limited, Annual General Meeting, Aug 20, 2024

GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director

GKB Ophthalmics Limited, Annual General Meeting, Sep 14, 2023

Insufficient new directors

Insufficient new directors

Insufficient new directors

Recent updates

Second quarter 2025 earnings released: ₹2.41 loss per share (vs ₹2.32 loss in 2Q 2024)

GKB Ophthalmics Limited to Report Q2, 2025 Results on Nov 14, 2024

First quarter 2025 earnings released: ₹0.50 loss per share (vs ₹1.04 profit in 1Q 2024)

GKB Ophthalmics Limited to Report Q1, 2025 Results on Aug 13, 2024

Full year 2024 earnings released: ₹5.58 loss per share (vs ₹0.33 loss in FY 2023)

GKB Ophthalmics Limited, Annual General Meeting, Aug 20, 2024

GKB Ophthalmics Limited to Report Q4, 2024 Results on May 30, 2024

New minor risk - Share price stability

GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director

Third quarter 2024 earnings released: ₹2.48 loss per share (vs ₹2.05 loss in 3Q 2023)

GKB Ophthalmics Limited to Report Q3, 2024 Results on Feb 14, 2024

Second quarter 2024 earnings released: ₹2.32 loss per share (vs ₹1.68 profit in 2Q 2023)

First quarter 2024 earnings released: EPS: ₹1.04 (vs ₹3.84 in 1Q 2023)

Full year 2023 earnings released: ₹0.33 loss per share (vs ₹2.53 profit in FY 2022)

GKB Ophthalmics Limited, Annual General Meeting, Sep 14, 2023

Investor sentiment improves as stock rises 16%

GKB Ophthalmics Limited to Report Q4, 2023 Results on May 30, 2023

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 22%

Third quarter 2023 earnings released: ₹2.05 loss per share (vs ₹1.63 profit in 3Q 2022)

Investor sentiment improves as stock rises 20%

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹1.68 (vs ₹0.67 loss in 2Q 2022)

Insufficient new directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Insufficient new directors

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: ₹3.84 (vs ₹0.27 in 1Q 2022)

GKB Ophthalmics Limited to Report Q1, 2023 Results on Aug 12, 2022

Investor sentiment improved over the past week

GKB Ophthalmics Limited to Report Q4, 2022 Results on May 30, 2022

Insufficient new directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Insufficient new directors

First quarter 2022 earnings released: EPS ₹0.27 (vs ₹3.68 loss in 1Q 2021)

Full year 2021 earnings released: ₹1.80 loss per share (vs ₹3.65 loss in FY 2020)

GKB Ophthalmics Limited to Report Q3, 2021 Results on Feb 10, 2021

New 90-day high: ₹60.00

New 90-day low: ₹47.25

First quarter earnings released

Full year earnings released - ₹3.65 loss per share

GKB Ophthalmics Limited to Report Q1, 2021 Results on Aug 19, 2020

New 90-day low - ₹52.65

GKB Ophthalmics Limited to Report Q2, 2020 Results on Sep 07, 2020

New 90-day low - ₹55.25

CEO Compensation Analysis

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age